Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma (HNJ-NKAES-2012)
Salvage Therapy With Chemotherapy and Natural Killer Cells in Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma.
Sponsor: Hospital Infantil Universitario Niño Jesús, Madrid, Spain
Terminated
The low recruitment rate makes it very difficult to complete the study within a reasonable period of time.
Other terminated trials from Hospital Infantil Universitario Niño Jesús, Madrid, Spain
See all terminations from Hospital Infantil Universitario Niño Jesús, Madrid, Spain
A PHASE1/PHASE2 clinical study on Relapsed/Refractory Paediatric T Cell Lymphoblastic Leukaemia and Lymphoma, this trial is terminated or withdrawn. The trial is conducted by Hospital Infantil Universitario Niño Jesús, Madrid, Spain and has accumulated 9 data snapshots since 2013. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
9 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE1/PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE1/PHASE2
Phase: PHASE1_PHASE2 → PHASE1/PHASE2
-
Dec 2021 — Jul 2024 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE1_PHASE2
-
Nov 2020 — Jan 2021 [monthly]
Terminated PHASE1_PHASE2
▶ Show 4 earlier versions
-
Jun 2018 — Nov 2020 [monthly]
Terminated PHASE1_PHASE2
-
May 2018 — Jun 2018 [monthly]
Terminated PHASE1_PHASE2
-
Aug 2017 — May 2018 [monthly]
Terminated PHASE1_PHASE2
-
Jan 2017 — Aug 2017 [monthly]
Terminated PHASE1_PHASE2
First recorded
Jul 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Infantil Universitario Niño Jesús, Madrid, Spain
For direct contact, visit the study record on ClinicalTrials.gov .